Epigenetics in diagnosis of colorectal cancer
Journal: Molecular Biology Research Communications (Vol.5, No. 1)Publication Date: 2016-03-01
Authors : Aga Syed Sameer; Saniya Nissar;
Page : 49-57
Keywords : Colorectal Cancer; Epigenetics; Hypermethylation; Biomarkers;
Abstract
Colorectal cancer (CRC) is a third most common epithelial carcinoma. CRC is known to develop from the early precancerous lesion to full blown malignancy via definite phases due to cumulative mutations and aberrant methylation of number of genes. The use of serum biomarkers that is non-invasive to discriminate cancer patients from healthy persons will prove to be an important tool to improve the early diagnosis of CRC. This will serve as the boon to the clinical management of the disease.
Other Latest Articles
- Analysis of IL-33 gene polymorphism (rs11792633 C/T) and risk of schizophrenia
- Design, simplified cloning, and in-silico analysis of multisite small interfering RNA-targeting cassettes
- Design of new potent HTLV-1 protease inhibitors: in silico study
- Omentin-1 rs2274907 and resistin rs1862513 polymorphisms influence genetic susceptibility to nonalcoholic fatty liver disease
- L-asparaginase production in the pseudomonas pseudoalcaligenes strain JHS-71 isolated from Jooshan Hot-spring
Last modified: 2016-04-11 14:52:13